Effect of race on the safety and efficacy of pemetrexed (P) therapy in locally advanced and metastatic non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Tai, D. F. [1 ]
Kulkarni, P. [1 ]
Wang, Y. [1 ]
Gill, J. [1 ]
Obasaju, C. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18082
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Proton therapy for locally advanced non-small cell lung cancer
    Gjyshi, Olsi
    Liao, Zhongxing
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2020, 93 (1107):
  • [32] Pemetrexed-based chemotherapy in advanced nonsquamous non-small cell lung cancer (NSCLC).
    Alshehri, Abdulrahman Ali
    Alsubait, Saud Abdullrhman
    Alamgir, M. Ahsan
    Park, Chandler
    Wen, Sijin
    Luo, Jin
    Ma, Patrick
    Monga, Manish
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Treatment of locally advanced and metastatic non-small cell lung cancer in the elderly
    Zimmermann, FB
    Molls, M
    Jeremic, B
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (01) : 203 - +
  • [34] The use of pemetrexed in advanced non-small cell lung cancer
    Ng, C.
    Harris, M. A.
    Burt, P. A.
    Sheikh, H. S.
    Lee, L.
    Blackhall, F. H.
    Summers, Y.
    Taylor, P.
    Coote, J.
    Chittalia, A.
    Califano, R.
    Bayman, N.
    [J]. LUNG CANCER, 2014, 83 : S12 - S12
  • [35] Efficacy and safety of bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer (NSCLC)
    Tassinari, D.
    Drudi, F.
    Carloni, F.
    Nicoletti, S.
    Possenti, C.
    Santelmo, C.
    Lazzari, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] EFFICACY OF PEMETREXED IN ADVANCED NON-SMALL CELL LUNG CANCER WITH ASYMPTOMATIC BRAIN METASTASES
    Kitai, Hidenori
    Asahina, Hajime
    Takashina, Taichi
    Ikezawa, Yasuyuki
    Sakakibara-Konishi, Jyunn
    Shinagawa, Naofumi
    Oizumi, Satoshi
    Nishimura, Masaharu
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S867 - S867
  • [37] Comparison of pemetrexed plus cisplatin versus pemetrexed plus carboplatin in the initial treatment of locally advanced or metastatic non-small cell lung cancer
    Pereira, A. A. R.
    Lessa, R. C.
    Souza, C. E. P.
    Pinto, F. A. I.
    Gagliato, D. M.
    Santos, E. S.
    Fanelli, M. F.
    Rinck, J. A.
    Dettino, A. A.
    Nicolau, U. R.
    Chinen, L. T. D.
    de Lima, V. C. C.
    Pereira, J. R.
    Cruz, M. R. D. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] Pemetrexed for treatment of advanced non-small cell lung cancer
    Fossella, FV
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (01) : 100 - 105
  • [39] Efficacy and safety study of osimertinib in advanced non-small cell lung cancer (NSCLC) with EGFR mutation
    Garcia Samblas, Victoria
    Fernandez Madrigal, Laura
    Rodriguez Garces, Maria Yeray
    Inoriza, Angel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Approval Summary: Erlotinib Maintenance Therapy of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Cohen, Martin H.
    Johnson, John R.
    Chattopadhyay, Somesh
    Tang, Shenghui
    Justice, Robert
    Sridhara, Rajeshwari
    Pazdur, Richard
    [J]. ONCOLOGIST, 2010, 15 (12): : 1344 - 1351
12345